Logo image of MDV

MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

NYSE:MDV - New York Stock Exchange, Inc. - US60784B1017 - REIT - Currency: USD

14.39  +0.27 (+1.91%)

After market: 14.39 0 (0%)

Fundamental Rating

4

Taking everything into account, MDV scores 4 out of 10 in our fundamental rating. MDV was compared to 130 industry peers in the Diversified REITs industry. MDV has an average financial health and profitability rating. MDV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

MDV had negative earnings in the past year.
In the past year MDV had a positive cash flow from operations.
MDV had negative earnings in 4 of the past 5 years.
MDV had a positive operating cash flow in each of the past 5 years.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -0.12%, MDV is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
The Return On Equity of MDV (-0.35%) is worse than 60.00% of its industry peers.
MDV has a Return On Invested Capital (3.12%) which is comparable to the rest of the industry.
MDV had an Average Return On Invested Capital over the past 3 years of 2.12%. This is in line with the industry average of 3.16%.
The 3 year average ROIC (2.12%) for MDV is below the current ROIC(3.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.12%
ROE -0.35%
ROIC 3.12%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

MDV has a better Operating Margin (42.50%) than 87.69% of its industry peers.
MDV's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 92.54%, MDV belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
MDV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 42.5%
PM (TTM) N/A
GM 92.54%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDV is destroying value.
The number of shares outstanding for MDV has been increased compared to 1 year ago.
MDV has more shares outstanding than it did 5 years ago.
MDV has a worse debt/assets ratio than last year.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.10, we must say that MDV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MDV (0.10) is worse than 72.31% of its industry peers.
MDV has a debt to FCF ratio of 25.54. This is a negative value and a sign of low solvency as MDV would need 25.54 years to pay back of all of its debts.
The Debt to FCF ratio of MDV (25.54) is better than 74.62% of its industry peers.
A Debt/Equity ratio of 1.63 is on the high side and indicates that MDV has dependencies on debt financing.
MDV has a Debt to Equity ratio of 1.63. This is in the lower half of the industry: MDV underperforms 65.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 25.54
Altman-Z 0.1
ROIC/WACC0.39
WACC7.95%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 4.88 indicates that MDV has no problem at all paying its short term obligations.
MDV has a better Current ratio (4.88) than 93.85% of its industry peers.
A Quick Ratio of 4.88 indicates that MDV has no problem at all paying its short term obligations.
MDV's Quick ratio of 4.88 is amongst the best of the industry. MDV outperforms 93.85% of its industry peers.
Industry RankSector Rank
Current Ratio 4.88
Quick Ratio 4.88
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

MDV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.50%, which is quite impressive.
Looking at the last year, MDV shows a decrease in Revenue. The Revenue has decreased by -4.13% in the last year.
The Revenue has been growing by 13.76% on average over the past years. This is quite good.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.03%
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%-1.45%

3.2 Future

MDV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.94% yearly.
MDV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.34% yearly.
EPS Next Y-69.03%
EPS Next 2Y-23.9%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue Next Year2.68%
Revenue Next 2Y3.56%
Revenue Next 3Y2.24%
Revenue Next 5Y2.34%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MDV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 99.40 indicates a quite expensive valuation of MDV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDV is on the same level as its industry peers.
MDV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE N/A
Fwd PE 99.4
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDV is valued a bit cheaper than the industry average as 71.54% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MDV is valued cheaply inside the industry as 86.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.3
EV/EBITDA 11.62
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.9%
EPS Next 3Y2.94%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.14%, MDV is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.64, MDV pays a better dividend. On top of this MDV pays more dividend than 81.54% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, MDV pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.14%

5.2 History

MDV has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MDV are negative and hence is the payout ratio. MDV will probably not be able to sustain this dividend level.
DP-2417.04%
EPS Next 2Y-23.9%
EPS Next 3Y2.94%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

More info and screens

MODIV INDUSTRIAL INC

NYSE:MDV (6/27/2025, 8:04:01 PM)

After market: 14.39 0 (0%)

14.39

+0.27 (+1.91%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)N/A N/A
Inst Owners17.04%
Inst Owner Change38.22%
Ins Owners2.92%
Ins Owner Change2.17%
Market Cap145.63M
Analysts84.44
Price Target18.05 (25.43%)
Short Float %0.49%
Short Ratio0.94
Dividend
Industry RankSector Rank
Dividend Yield 8.14%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-2417.04%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.0975)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)143.79%
Min EPS beat(2)88.58%
Max EPS beat(2)199.01%
EPS beat(4)3
Avg EPS beat(4)-61.77%
Min EPS beat(4)-694.06%
Max EPS beat(4)199.01%
EPS beat(8)5
Avg EPS beat(8)48.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)1.93%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-4.05%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.67%
PT rev (3m)-2.57%
EPS NQ rev (1m)-40%
EPS NQ rev (3m)200%
EPS NY rev (1m)-34.28%
EPS NY rev (3m)169.7%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 99.4
P/S 3.13
P/FCF 13.3
P/OCF 7.96
P/B 0.85
P/tB 0.86
EV/EBITDA 11.62
EPS(TTM)-0.09
EYN/A
EPS(NY)0.14
Fwd EY1.01%
FCF(TTM)1.08
FCFY7.52%
OCF(TTM)1.81
OCFY12.57%
SpS4.6
BVpS16.91
TBVpS16.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.12%
ROE -0.35%
ROCE 3.95%
ROIC 3.12%
ROICexc 3.16%
ROICexgc 3.19%
OM 42.5%
PM (TTM) N/A
GM 92.54%
FCFM 23.51%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexcg growth 3Y59.93%
ROICexcg growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 25.54
Debt/EBITDA 7.75
Cap/Depr 45.14%
Cap/Sales 15.78%
Interest Coverage 1.5
Cash Conversion 50.72%
Profit Quality N/A
Current Ratio 4.88
Quick Ratio 4.88
Altman-Z 0.1
F-Score5
WACC7.95%
ROIC/WACC0.39
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.03%
EPS Next Y-69.03%
EPS Next 2Y-23.9%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%-1.45%
Revenue Next Year2.68%
Revenue Next 2Y3.56%
Revenue Next 3Y2.24%
Revenue Next 5Y2.34%
EBIT growth 1Y117.17%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year80.32%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y114.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.76%
OCF growth 3Y23.3%
OCF growth 5Y30.88%